Found: 2
Select item for more details and to access through your institution.
HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
- Published in:
- World Journal of Surgical Oncology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12957-023-03176-6
- By:
- Publication type:
- Article
USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 10, p. 1, doi. 10.1038/s41419-023-06172-6
- By:
- Publication type:
- Article